Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C21H19NO4 |
| Molecular Weight | 349.3799 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C=C1)N(C(=O)C3=CC=CC=C3)C4=C2CC(CC4)C(O)=O
InChI
InChIKey=ZNHCPKKNDKCPDG-UHFFFAOYSA-N
InChI=1S/C21H19NO4/c1-26-15-8-10-19-17(12-15)16-11-14(21(24)25)7-9-18(16)22(19)20(23)13-5-3-2-4-6-13/h2-6,8,10,12,14H,7,9,11H2,1H3,(H,24,25)
| Molecular Formula | C21H19NO4 |
| Molecular Weight | 349.3799 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/115021
Sources: https://www.ncbi.nlm.nih.gov/pubmed/115021
Oxarbazole was developed as an antiasthmatic agent that inhibited the only bronchoconstriction induced by immune complexes. This drug has never been marketed.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 07:50:09 GMT 2025
by
admin
on
Wed Apr 02 07:50:09 GMT 2025
|
| Record UNII |
A34YCH7N8A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29712
Created by
admin on Wed Apr 02 07:50:09 GMT 2025 , Edited by admin on Wed Apr 02 07:50:09 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
35578-20-2
Created by
admin on Wed Apr 02 07:50:09 GMT 2025 , Edited by admin on Wed Apr 02 07:50:09 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105332
Created by
admin on Wed Apr 02 07:50:09 GMT 2025 , Edited by admin on Wed Apr 02 07:50:09 GMT 2025
|
PRIMARY | |||
|
C81436
Created by
admin on Wed Apr 02 07:50:09 GMT 2025 , Edited by admin on Wed Apr 02 07:50:09 GMT 2025
|
PRIMARY | |||
|
SUB09503MIG
Created by
admin on Wed Apr 02 07:50:09 GMT 2025 , Edited by admin on Wed Apr 02 07:50:09 GMT 2025
|
PRIMARY | |||
|
100000083032
Created by
admin on Wed Apr 02 07:50:09 GMT 2025 , Edited by admin on Wed Apr 02 07:50:09 GMT 2025
|
PRIMARY | |||
|
37184
Created by
admin on Wed Apr 02 07:50:09 GMT 2025 , Edited by admin on Wed Apr 02 07:50:09 GMT 2025
|
PRIMARY | |||
|
C016025
Created by
admin on Wed Apr 02 07:50:09 GMT 2025 , Edited by admin on Wed Apr 02 07:50:09 GMT 2025
|
PRIMARY | |||
|
DTXSID00865777
Created by
admin on Wed Apr 02 07:50:09 GMT 2025 , Edited by admin on Wed Apr 02 07:50:09 GMT 2025
|
PRIMARY | |||
|
A34YCH7N8A
Created by
admin on Wed Apr 02 07:50:09 GMT 2025 , Edited by admin on Wed Apr 02 07:50:09 GMT 2025
|
PRIMARY | |||
|
4289
Created by
admin on Wed Apr 02 07:50:09 GMT 2025 , Edited by admin on Wed Apr 02 07:50:09 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |